UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013524
Receipt number R000015806
Scientific Title The study for the effect of the reinforcing material on the treatment for the patients with inflammatory bowel disease.
Date of disclosure of the study information 2014/05/01
Last modified on 2018/09/28 12:38:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study for the effect of the reinforcing material on the treatment for the patients with inflammatory bowel disease.

Acronym

The study for the effect of the reinforcing material on the treatment for the patients with IBD.

Scientific Title

The study for the effect of the reinforcing material on the treatment for the patients with inflammatory bowel disease.

Scientific Title:Acronym

The study for the effect of the reinforcing material on the treatment for the patients with IBD.

Region

Japan


Condition

Condition

Inflammatory Bowel Disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of the treatment with reinforcing material for intestinal ulcer of the patients with inflammatory bowel disease is analyzed.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The size of ulcer, mucosal healing by the endoscopic finding.
The structure of the villi and the degree of inflammation by the pathological findings of the biopsy specimen

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The cover of the reinforcing material on the refractory ulcer of the patients with IBD.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with IBD who has the ulcers in rectum by the endoscopy in spite of the therapy for IBD.

Key exclusion criteria

The patients with contraindications for the endoscopy and biopsy.
Pregnant patients or possible pregnant patients. The patients who have past history of the allergy to the reinforcing material. The patients who take medicines inducing the interaction with the reinforcing material.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mamoru Watanabe

Organization

Tokyo Medical and Dental University

Division name

Gastroenterology and Hepatology

Zip code


Address

1-5-45, Yushima Bunkyo-ku, Tokyo

TEL

03-5803-5973

Email

mamoru.gast@tmd.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kiichiro Tsuchiya

Organization

Tokyo Medical and Dental University

Division name

Advanced Therapeutics for Gastrointestinal Diseases

Zip code


Address

1-5-45, Yushima Bunkyo-ku, Tokyo

TEL

03-5803-5974

Homepage URL


Email

kii.gast@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Research Center Network for Realization of Regenerative Medicine

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 05 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry

2018 Year 03 Month 31 Day

Date trial data considered complete

2018 Year 03 Month 31 Day

Date analysis concluded

2018 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 03 Month 26 Day

Last modified on

2018 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015806


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name